Riskpilot← Back to searchSign inGet full accessOXITRATE AS
ASActiveOrg 986884165Holterkollveien 6, 1448 DrøbakRental and leasing of other machinery, equipment and tangible goods n.e.c. · NACE 7739Est. 20048 employees
Revenue 2024
NOK 21,7M
+24% vs 2023
EBITDA margin
10.5%
+20% vs 2023
Equity ratio
44.8%
Financial strength
Net profit 2024
NOK 538K
-17% vs 2023
| Revenue | NOK 21,7M | +24% |
| EBITDA | NOK 2,3M | +20% |
| Net profit | NOK 538K | -17% |
| Total assets | NOK 26,7M | +14% |
| Equity | NOK 11,9M | +5% |
| Employees | 8 | — |
Legal name
OXITRATE AS
Org number
986884165
Legal form
Aksjeselskap
NACE code
7739 · Rental and leasing of other machinery, equipment and tangible goods n.e.c.
Founded
16. juni 2004
Share capital
NOK 6 159 582
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Selskapet utvikler og driver elektrokjemisk forskning og produktutvikling for desinfeksjon samt produksjon og salg.
Address
Holterkollveien 6, 1448 Drøbak
Email
info@medis.si
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 811 | 3 579 | 1 129 | 564 | 307 | 1 399 | 469 | 615 | 881 | 1 047 | 2 279 | 3 131 | 8 271 | 11 685 | 12 749 | 17 464 | 21 688 |
| Staff expenses | −0 | −74 | −2 | −0 | −0 | −69 | −38 | −0 | −3 | −0 | −304 | −285 | −1 112 | −1 538 | −2 724 | −2 832 | −2 319 |
| EBITDA | 27 | 1 116 | −300 | −981 | −144 | 584 | −347 | 142 | 280 | 270 | 392 | 725 | 1 155 | 890 | 857 | 1 892 | 2 268 |
| Depreciation & amort. | −0 | −3 | −5 | −566 | −723 | −726 | −640 | −240 | −240 | −236 | −264 | −289 | −559 | −655 | −843 | −1 290 | −1 611 |
| EBIT | 27 | 1 113 | −305 | −1 548 | −867 | −142 | −987 | −98 | 40 | 34 | 127 | 435 | 595 | 235 | 15 | 602 | 657 |
| Net financials | 1 | −15 | 0 | −4 | −3 | −2 | −6 | −3 | −1 | −0 | 2 | −6 | −53 | −164 | −81 | −173 | −746 |
| Profit before tax | 27 | 1 098 | −304 | −1 552 | −870 | −144 | −994 | −100 | 39 | 34 | 130 | 430 | 542 | 72 | −67 | 429 | −89 |
| Tax | 8 | 393 | −85 | 228 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −43 | −220 | −223 | −627 |
| Net profit | 20 | 706 | −219 | −1 780 | −870 | −144 | −994 | −100 | 39 | 34 | 130 | 430 | 542 | 114 | 153 | 652 | 538 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 201 | 2 250 | 3 802 | 3 810 | 3 160 | 3 111 | 2 215 | 2 061 | 1 962 | 2 217 | 2 600 | 4 063 | 8 544 | 8 234 | 13 364 | 23 436 | 26 677 |
| Equity | 930 | 1 636 | 1 416 | −364 | −1 234 | 423 | −571 | 1 828 | 1 867 | 1 901 | 2 031 | 2 461 | 3 028 | 3 142 | 10 753 | 11 405 | 11 943 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 833 | 1 167 | 500 | 3 233 | 4 657 |
| Short-term debt | 271 | 614 | 2 386 | 4 174 | 4 393 | 2 688 | 2 786 | 233 | 95 | 316 | 569 | 1 602 | 3 682 | 3 925 | 2 110 | 8 798 | 10 076 |
| Total debt | 271 | 614 | 2 386 | 4 174 | 4 393 | 2 688 | 2 786 | 233 | 95 | 316 | 569 | 1 602 | 5 516 | 5 092 | 2 610 | 12 031 | 14 734 |
EBITDA margin
10.5%
This company
15.8%
Market median
-34% vs market
20082024
Equity ratio
44.8%
This company
38.2%
Market median
+17% vs market
20082024
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20082024
Net profit margin
2.5%
This company
8.1%
Market median
-69% vs market
20082024
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20082024
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DW Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
TW Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
SB Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
MF Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Wauer Invest As | Company | 35.8% | 35.8% | 2024 |
Box Holding As | Company | 22.3% | 22.3% | 2024 |
Solsten As | Company | 16.9% | 16.9% | 2024 |
Summen As | Company | 6.5% | 6.5% | 2024 |
| Individual | 3.7% | 3.7% | 2024 | |
Oxitrate As | Company | 3.3% | 3.3% | 2024 |
| Individual | 2.6% | 2.6% | 2024 | |
Tananua As | Company | 2.6% | 2.6% | 2024 |
| Individual | 1.3% | 1.3% | 2023 | |
Namo As | Company | 1.3% | 1.3% | 2024 |
| Individual | 1.1% | 1.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Marchfirst Norway As
OXITRATE AS Board members of OXITRATE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dennis Wauer | Chief Executive Officer | 0 companies |
| Tor Wauer | Chief Executive Officer | 0 companies |
| Svein Bolkesjø Bentzen | Chief Executive Officer | 0 companies |
| Morten Fredriksen | Chief Executive Officer | 0 companies |
| Svein Bentzen | Board of Directors | 0 companies |
| Jon Are Ulfsrud | Board of Directors | 0 companies |
| Kjell Ole Simonsen | Chairman | 0 companies |
| Petter Mannsverk Andresen | Chairman | 0 companies |
| Bjørn Moldskred | Board of Directors | 0 companies |
| Per Kristian Jacobsen | Chairman | 0 companies |